Kanaph Therapeutics Inc.

Sentiment around initial public offerings (IPOs) appears to be slowly recovering in South Korea as the market stabilizes somewhat amid ongoing political uncertainties at home and abroad. A couple of b

With the long-awaited global commercialization of lazertinib, Oscotec Inc. and its US subsidiary Genosco, the originators of the novel lung cancer drug, are poised to see a steady inflow of revenues

The hopes of spring may be returning to the South Korean biotech industry after a series of encouraging developments in recent months has more than made up for some other disappointing news, with prog

During the course of conducting interviews, attending conferences and providing other coverage of the region, Scrip 's team in APAC often hears comments and views that are worth highlighting by thems